阿里拉姆制药2025财年第二财季实现净利润-66.28百万美元,同比减少292.42%

市场透视
Aug 09

8月9日,阿里拉姆制药(ALNY.US)公布财报,公告显示公司2025财年第二财季净利润为-66.28百万美元,同比减少292.42%;其中营业收入为7.74亿美元,同比增加17.27%,每股基本收益为-0.51美元。从资产负债表来看,阿里拉姆制药(ALNY.US)总负债43.15亿美元,其中短期债务1.44亿美元,资产负债比为1.06,流动比率为2.81。机构评级:截至2025年8月9日,当前有...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10